Compensation Failure as the Mechanism of Psychosis in 22q11.2 Deletion Syndrome: A Falsifiable Model

The 22q11.2 deletion raises psychosis risk roughly twentyfold, yet most carriers never become psychotic. That gap, not the deletion’s biology, is the explanandum, and most of the cellular literature cannot address it: it compares carriers who have schizophrenia with healthy controls, so what it identifies belongs to the combined deletion-and-illness group and cannot be assigned to the deletion alone. This article proposes that the deleted genes with demonstrated neural phenotypes are dosage-limiting for rates, gains and throughputs rather than for structures, so that hemizygosity narrows the range over which a controlled variable can be corrected. The predicted phenotype is bidirectional instability of set points, which is what is observed: connectivity is in surplus before puberty and in deficit after it in deletion mice and in carriers; synaptic transcripts rise while presynaptic proteins fall; neurons are more excitable while their evoked calcium transients are smaller. The model holds that every carrier compensates, and states itself in six separately defined quantities, each with a proposed measurement or proxy — demand, intrinsic capacity, effort, effective capacity, output and reserve — so that its predictions can differ in sign between them and cannot be averaged into one. Psychosis is placed where the rising demand of adolescent remodeling crosses a falling capacity, with the timing set by regulatory trajectories. The sharpest consequence inverts the usual case-control logic: on compensatory effort the protected carrier should be abnormal beyond controls, not normal, and the one cellular study to have measured compensatory-effort variables in carriers with and without schizophrenia reports that ordering. Because the state is an imbalance rather than accumulated damage, positive symptoms should remit while negative symptoms and functional impairment persist, and they do. Dopamine is placed as a downstream compensator with a perceptual cost rather than a final common pathway. Four prespecified programs state what would falsify the model, with evidence for, evidence against, and inconclusive outcomes defined in advance.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-12
DOI
https://doi.org/10.5281/zenodo.24150976
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Compensation Failure as the Mechanism of Psychosis in 22q11.2 Deletion Syndrome: A Falsifiable Model

Tyler M. Moore
Zenodo (CERN European Organization for Nuclear Research)
Schizophrenia research and treatment
article

Compensation Failure as the Mechanism of Psychosis in 22q11.2 Deletion Syndrome: A Falsifiable Model

Tyler M. Moore
article en

Abstract

The 22q11.2 deletion raises psychosis risk roughly twentyfold, yet most carriers never become psychotic. That gap, not the deletion’s biology, is the explanandum, and most of the cellular literature cannot address it: it compares carriers who have schizophrenia with healthy controls, so what it identifies belongs to the combined deletion-and-illness group and cannot be assigned to the deletion alone. This article proposes that the deleted genes with demonstrated neural phenotypes are dosage-limiting for rates, gains and throughputs rather than for structures, so that hemizygosity narrows the range over which a controlled variable can be corrected. The predicted phenotype is bidirectional instability of set points, which is what is observed: connectivity is in surplus before puberty and in deficit after it in deletion mice and in carriers; synaptic transcripts rise while presynaptic proteins fall; neurons are more excitable while their evoked calcium transients are smaller. The model holds that every carrier compensates, and states itself in six separately defined quantities, each with a proposed measurement or proxy — demand, intrinsic capacity, effort, effective capacity, output and reserve — so that its predictions can differ in sign between them and cannot be averaged into one. Psychosis is placed where the rising demand of adolescent remodeling crosses a falling capacity, with the timing set by regulatory trajectories. The sharpest consequence inverts the usual case-control logic: on compensatory effort the protected carrier should be abnormal beyond controls, not normal, and the one cellular study to have measured compensatory-effort variables in carriers with and without schizophrenia reports that ordering. Because the state is an imbalance rather than accumulated damage, positive symptoms should remit while negative symptoms and functional impairment persist, and they do. Dopamine is placed as a downstream compensator with a perceptual cost rather than a final common pathway. Four prespecified programs state what would falsify the model, with evidence for, evidence against, and inconclusive outcomes defined in advance.

Zenodo (CERN European Organization for Nuclear Research)
University of Pennsylvania (US)
Good health and well-being
Schizophrenia research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon